首页> 美国卫生研究院文献>Eurosurveillance >More than 20 years after re-emerging in the 1990s diphtheria remains a public health problem in Latvia
【2h】

More than 20 years after re-emerging in the 1990s diphtheria remains a public health problem in Latvia

机译:在1990年代重新出现20多年后白喉仍然是拉脱维亚的公共卫生问题

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In 1994, the World Health Organization (WHO) declared the goal of eliminating diphtheria within the WHO European Region by the year 2000. However, in 1990 an epidemic emerged within the Russian Federation and spread to other countries, including Latvia, by 1994. We describe national surveillance and immunisation coverage data in Latvia from 1994 to 2014 and present historical data from 1946. We defined a laboratory-confirmed case as a clinical case in which toxin-producing Corynebacterium diphtheriae, C. ulcerans or C. pseudotuberculosis was isolated. From 1994 to 2014, 1,515 cases were reported, giving an average annual incidence of 3.2 cases per 100,000 inhabitants (range 0.1–14.8), with the highest incidence in age groups 5–19 and 40–49 years (4.4 and 4.3/100,000, respectively); 111 deaths were reported, 83.8% cases were laboratory-confirmed. Most cases occurred in unvaccinated adults. To improve disease control a supplementary immunisation campaign for adults was initiated in 1995, and by the end of 1998 national coverage among adults reached 70%, and reached 77% in 2003, but declined to 59% by 2014. Diphtheria remains a problem in Latvia with continued circulation of toxin-producing strains of C. diphtheriae. We recommend to strengthen immunisation to cover adults, as well as the education of health professionals and a serological survey.
机译:1994年,世界卫生组织(WHO)宣布了到2000年在世界卫生组织欧洲区域内消除白喉病的目标。但是,在1990年,俄罗斯联邦开始流行,并在1994年蔓延到包括拉脱维亚在内的其他国家。描述了1994年至2014年在拉脱维亚的国家监测和免疫覆盖率数据,并提供了1946年的历史数据。我们将实验室确诊的病例定义为临床病例,在该病例中,分离出了产生毒素的白喉棒状杆菌,溃疡杆菌或假结核杆菌。从1994年到2014年,报告了1515例病例,每10万居民平均每年发生3.2例病例(范围为0.1-14.8),其中5-19岁和40-49岁年龄段的发病率最高(4.4和4.3 / 100,000,分别);报告死亡111人,经实验室确诊的病例为83.8%。大多数病例发生在未接种疫苗的成年人中。为了改善疾病控制,1995年发起了针对成年人的补充免疫运动,到1998年底,全国成年人覆盖率达到70%,2003年达到77%,但到2014年下降到59%。白喉仍然是拉脱维亚的问题不断循环产生毒素的白喉衣原体。我们建议加强针对成人的免疫接种,以及卫生专业人员的教育和血清学调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号